News and updates

Advanced Therapies (ATMPs)

3PBIOVIAN Contributes to Advancing Personalized Cancer Immunotherapies Through the PITÁGORAS Project

August 6, 2026

First cellularized collagen membrane implant to regenerate heart tissue in patients with ischemic heart disease

December 20, 2019

Say hello.

Passionate about progress and people, we work in harmony with our partners, always close, all the way.

"*" indicates required fields

First name*

Last Name*

Email*

Company*

Service Interest

Comments

By submitting this form, 3P BIOPHARMACEUTICALS, S.L.U. will use the personal data you provide us with to send you the requested information. It is hereby informed that the services of this website are intended for adults (individuals who have reached the legal age). You may withdraw your consent at any time by notifying us at complianceofficer@3pbio.com. Such withdrawal will not affect the lawfulness of any processing based on consent given prior to its withdrawal.

Consent Privacy Policy*

I hereby consent to the processing of my personal data for the specific purpose of addressing the contact form.*

Consent Newsletter*

I consent to receive commercial communications and/or newsletters from 3P BIOPHARMACEUTICALS, S.L.U.*

Services

Proteins
- Microbial Proteins
- Mammalian Proteins
Viral Vectors
Plasmid DNA
Cell Therapies
Other Services

Company

About us
Contact
Careers

Legal

Privacy Policy
Cookies Policy
Whistleblower Policy
Legal Notice

LinkedIn